Vascular Diseases  >>  selonsertib (GS-4997)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
selonsertib (GS-4997) / Gilead
ARROW, NCT02234141 / 2014-002131-34: Selonsertib in Adults With Pulmonary Arterial Hypertension

Completed
2
151
Canada, US, Europe
Placebo, GS-4997, Selonsertib
Gilead Sciences
Pulmonary Arterial Hypertension
04/16
12/16

Download Options